Union Bancaire Privee, Ubp Sa Biomarin Pharmaceutical Inc Transaction History
Union Bancaire Privee, Ubp Sa
- $4.81 Billion
- Q4 2024
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 3,000 shares of BMRN stock, worth $187,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$187,590% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
639Shares Held
178MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.42 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.21 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.18 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$869 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$656 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...